|  | Conditions Treatments | Alzheimers

EMI and Dementia

Dementia and other elderly mental infirmities--EMIs--afflict over 30 million people worldwide, according to the Alzheimer's Disease International Organization, which predicts this number will grow to over 100 million by the year 2050. Organizations around the world have joined in the fight against Alzheimer's disease and other EMIs.

 

  1. Statistics

    • According to the Centers for Disease Control (CDC), as many as five million Americans suffer from Alzheimer's disease, the most common form of dementia. Other types of dementia affect an estimated 6 to 10 percent of individuals 65 and older, and organizations such as the Center for Dementia Research conduct ongoing studies to search for treatments and cures for EMIs.

       

    Geographical Considerations

    • The 10/66 Dementia Research Group, an organization coordinated by Kings College, London, England, states that 66 percent of EMI victims live in developing countries. The organization was created to increase research in these areas as less than 10 percent of studies for dementia and other EMIs are conducted in these parts of the world.

    Working Together

    • Announcements concerning the launch of "TrialMatchTM" were made on July 14, 2010 at the Alzheimer's Association's International Conference on Alzheimer's Disease in Honolulu, Hawaii. TrialMatchTM is a tool that matches individuals suffering from Alzheimer's disease or other dementias with clinical trials. The Alzheimer's Association and other organizations, such as the CDC and the World Health Organization (WHO), continue to work together in the fight against EMIs.

Alzheimers - Related Articles